Page last updated: 2024-11-04

alkannin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Alkannin is a natural red pigment found in the roots of the plant Alkanna tinctoria. It has been used for centuries as a dye and in traditional medicine. Alkannin has been shown to have a variety of biological activities, including anti-inflammatory, antioxidant, antimicrobial, and anticancer properties. It is thought to exert its effects by inhibiting the production of pro-inflammatory cytokines and by scavenging free radicals. Alkannin is currently being investigated for its potential use in the treatment of a variety of diseases, including cancer, inflammation, and infections. It is also being explored for its potential use as a natural food colorant and as a cosmetic ingredient.'

alkannin: a naphthazarin used to promote wound healing, from the plant Alkanna tinctoria; RN given refers to (S)-isomer; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

FloraRankFlora DefinitionFamilyFamily Definition
Alkannagenus[no description available]BoraginaceaeThe Borage plant family is in the class Magnoliopsida, subclass Asteridae, order Lamiales. It is characterized by hairy foliage, usually alternate and simple; flowers are funnel-shaped or tubular. Some of the species contain PYRROLIZIDINE ALKALOIDS.[MeSH]
Alkannagenus[no description available]BoraginaceaeThe Borage plant family is in the class Magnoliopsida, subclass Asteridae, order Lamiales. It is characterized by hairy foliage, usually alternate and simple; flowers are funnel-shaped or tubular. Some of the species contain PYRROLIZIDINE ALKALOIDS.[MeSH]

Cross-References

ID SourceID
PubMed CID72521
CHEMBL ID28457
CHEMBL ID4127840
CHEBI ID2578
SCHEMBL ID33968
MeSH IDM0069507
PubMed CID5208
CHEMBL ID29285
CHEBI ID174748
SCHEMBL ID3182028
SCHEMBL ID14305203
MeSH IDM0069507

Synonyms (130)

Synonym
5,8-dihydroxy-6-(1-hydroxy-4-methyl-3-pentenyl)-1,4-naphthalenedione, (s)-
1,4-naphthalenedione, 5,8-dihydroxy-6-(1-hydroxy-4-methyl-3-pentenyl)-, (s)-
brn 3213296
(-)-5,8-dihydroxy-6-(1-hydroxy-4-methyl-3-pentenyl)-1,4-naphthoquinone
1,4-naphthoquinone, 5,8-dihydroxy-6-(1-hydroxy-4-methyl-3-pentenyl)-, (-)-
(-)-(1-hydroxy-3-isohexenyl)naphthazarine
1,4-naphthalenedione, 5,8-dihydroxy-6-(1-hydroxy-4-methyl-3-pentenyl)-, (-)-
(-)-5,8-dihydroxy-6-(1-hydroxy-4-methyl-3-pentenyl)-1,4-naphthalenedione
cerven prirodni 20 [czech]
anchusa acid
alkanna red
alkannin
517-88-4
CHEMBL28457
e103
chebi:2578 ,
3-08-00-04089 (beilstein handbook reference)
cerven prirodni 20
nsc 407295
nsc 94524
alkanna red (van)
alkannin (van)
075crz9995 ,
einecs 208-245-7
anchusin (van)
unii-075crz9995
1,4-naphthalenedione, 5,8-dihydroxy-2-(1-hydroxy-4-methyl-3-pentenyl)-, (s)-
c.i. 75530 (van)
anchusa acid (van)
(s)-5,8-dihydroxy-2-(1-hydroxy-4-methylpent-3-enyl)-1,4-naphthoquinone
(-)-5,8-dihydroxy-2-(1-hydroxy-4-methyl-3-pentenyl)-1,4-naphthoquinone
alkannin [mi]
5,8-dihydroxy-2-((1s)-1-hydroxy-4-methylpent-3-en-1-yl)naphthalene-1,4-dione
alkannin(rg)
SCHEMBL33968
AC-26870
5,8-dihydroxy-2-[(1s)-1-hydroxy-4-methyl-pent-3-enyl]naphthalene-1,4-dione
AKOS025401887
alkannin, analytical standard
Q418237
bdbm50271717
chembl4127840 ,
anchusaic acid
arnebin iv
(s)-5,8-dihydroxy-2-(1-hydroxy-4-methylpent-3-enyl)naphthalene-1,4-dione
mfcd00189414
(-)-alkannin
(s)-5,8-dihydroxy-2-(1-hydroxy-4-methylpent-3-en-1-yl)naphthalene-1,4-dione
HY-119874
bdbm50597697
DTXSID201029621
CS-0078216
5,8-dihydroxy-2-[(1s)-1-hydroxy-4-methylpent-3-en-1-yl]-1,4-dihydronaphthalene-1,4-dione
LS-14485
CHEBI:174748
5,8-dihydroxy-2-(1-hydroxy-4-methylpent-3-enyl)naphthalene-1,4-dione
NSC94524 ,
NSC252844 ,
1, 5,8-dihydroxy-2-(1-hydroxy-4-methyl-3-pentenyl)-, (+)-
1, 5,8-dihydroxy-2-(1-hydroxy-4-methyl-3-pentenyl)-, (r)-
NCI60_002031
SMP2_000188
BIO2_000475
BIO2_000955
nsc-291845
54952-43-1
nsc291845
1, 5,8-dihydroxy-2-(1-hydroxy-4-methyl-3-pentenyl)-
arnebin-4
nsc-94524
IDI1_002230
QTL1_000075
nsc-407295
NSC407295 ,
1, 5,8-dihydroxy-2-(1-hydroxy-4-methyl-3-pentenyl)-, (-)-
anchusin
alkannin, 1-
c.i. 75530
1, 5,8-dihydroxy-6-(1-hydroxy-4-methyl-3-pentenyl)-, (-)-
1, 5,8-dihydroxy-2-(1-hydroxy-4-methyl-3-pentenyl)-, (s)-
c.i. natural red 20
KBIO3_001080
KBIO3_001079
KBIOGR_000610
KBIO2_003178
KBIO2_005746
KBIOSS_000610
KBIO2_000610
(+-)-shikonin
5,8-dihydroxy-2-[(1s)-1-hydroxy-4-methylpent-3-enyl]naphthalene-1,4-dione
HMS1362P11
FT-0651798
nezonwmxzkdmkf-uhfffaoysa-
inchi=1/c16h16o5/c1-8(2)3-4-10(17)9-7-13(20)14-11(18)5-6-12(19)15(14)16(9)21/h3,5-7,10,17-19h,4h2,1-2h3
shikalkin
nsc 291845
(+-)-shikalkin
(+-)-alkannin
1,4-naphthalenedione, 5,8-dihydroxy-2-(1-hydroxy-4-methyl-3-pentenyl)-
AKOS016034343
23444-65-7
c.i. natural red 20 (van)
CHEMBL29285
H1780
SCHEMBL3182028
5,8-dihydroxy-2-(1-hydroxy-4-methyl-pent-3-enyl)naphthalene-1,4-dione
5,8-dihydroxy-2-(1-hydroxy-4-methyl-3-pentenyl)-1,4-naphthoquinone
natural red 20
3-(2,2-dimethylpropionylamino)isonicotinicacid
Q-100621
SCHEMBL14305203
(+/-)-alkannin
(+/-)-shikonin
bdbm178090
shikonin (7b)
( inverted exclamation marka)-shikonin
shikonin, >=98% (hplc)
FT-0746742
FT-0774471
1,4-naphthalenedione, 5,8-dihydroxy-2-(1-hydroxy-4-methyl-3-pentenyl)- (9ci)
11019-15-1
BCP29329
(-)-shikonin;c.i. 75535; isoarnebin 4
BCP34282
5,8-dihydroxy-6-(1-hydroxy-4-methylpent-3-en-1-yl)naphthalene-1,4-dione
5,8-dihydroxy-2-(1-hydroxy-4-methylpent-3-en-1-yl)naphthalene-1,4-dione
DTXSID00862100
CS-0032051
HY-N6004
(rac)-shikonin
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (2)

ClassDescription
hydroxy-1,4-naphthoquinoneAny member of the class of 1,4-naphthoquinones in which the naphthoquinone moiety is substituted by at least one hydroxy group.
naphthoquinoneA polycyclic aromatic ketone metabolite of naphthalene.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (1)

PathwayProteinsCompounds
shikonin biosynthesis017

Protein Targets (6)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Pyruvate kinase PKMHomo sapiens (human)IC50 (µMol)0.90000.50002.788610.0000AID1881860; AID1881902
Class A sortase SrtA Staphylococcus aureusIC50 (µMol)2.68000.30002.86005.9000AID1494880; AID1494883
Replicase polyprotein 1abSevere acute respiratory syndrome-related coronavirusIC50 (µMol)15.75000.00402.92669.9600AID1805801
Replicase polyprotein 1abSevere acute respiratory syndrome coronavirus 2IC50 (µMol)15.75000.00022.45859.9600AID1803933; AID1805801
Amine oxidase [flavin-containing] AHomo sapiens (human)IC50 (µMol)1.25500.00002.37899.7700AID1801570
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Activation Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Replicase polyprotein 1abSevere acute respiratory syndrome coronavirus 2EC50 (µMol)4.67000.00304.11059.8200AID1803934
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Other Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
DNA topoisomerase 1Homo sapiens (human)MIC500.00000.01002.00175.0000AID228426
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (20)

Processvia Protein(s)Taxonomy
DNA topological changeDNA topoisomerase 1Homo sapiens (human)
chromatin remodelingDNA topoisomerase 1Homo sapiens (human)
circadian rhythmDNA topoisomerase 1Homo sapiens (human)
response to xenobiotic stimulusDNA topoisomerase 1Homo sapiens (human)
programmed cell deathDNA topoisomerase 1Homo sapiens (human)
phosphorylationDNA topoisomerase 1Homo sapiens (human)
peptidyl-serine phosphorylationDNA topoisomerase 1Homo sapiens (human)
circadian regulation of gene expressionDNA topoisomerase 1Homo sapiens (human)
embryonic cleavageDNA topoisomerase 1Homo sapiens (human)
chromosome segregationDNA topoisomerase 1Homo sapiens (human)
DNA replicationDNA topoisomerase 1Homo sapiens (human)
programmed cell deathPyruvate kinase PKMHomo sapiens (human)
canonical glycolysisPyruvate kinase PKMHomo sapiens (human)
positive regulation of sprouting angiogenesisPyruvate kinase PKMHomo sapiens (human)
positive regulation of cytoplasmic translationPyruvate kinase PKMHomo sapiens (human)
glycolytic processPyruvate kinase PKMHomo sapiens (human)
cellular response to insulin stimulusPyruvate kinase PKMHomo sapiens (human)
symbiont-mediated perturbation of host ubiquitin-like protein modificationReplicase polyprotein 1abSevere acute respiratory syndrome-related coronavirus
biogenic amine metabolic processAmine oxidase [flavin-containing] AHomo sapiens (human)
positive regulation of signal transductionAmine oxidase [flavin-containing] AHomo sapiens (human)
dopamine catabolic processAmine oxidase [flavin-containing] AHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (36)

Processvia Protein(s)Taxonomy
RNA polymerase II cis-regulatory region sequence-specific DNA bindingDNA topoisomerase 1Homo sapiens (human)
DNA bindingDNA topoisomerase 1Homo sapiens (human)
chromatin bindingDNA topoisomerase 1Homo sapiens (human)
double-stranded DNA bindingDNA topoisomerase 1Homo sapiens (human)
single-stranded DNA bindingDNA topoisomerase 1Homo sapiens (human)
RNA bindingDNA topoisomerase 1Homo sapiens (human)
DNA topoisomerase type I (single strand cut, ATP-independent) activityDNA topoisomerase 1Homo sapiens (human)
protein serine/threonine kinase activityDNA topoisomerase 1Homo sapiens (human)
protein bindingDNA topoisomerase 1Homo sapiens (human)
ATP bindingDNA topoisomerase 1Homo sapiens (human)
DNA binding, bendingDNA topoisomerase 1Homo sapiens (human)
protein domain specific bindingDNA topoisomerase 1Homo sapiens (human)
supercoiled DNA bindingDNA topoisomerase 1Homo sapiens (human)
magnesium ion bindingPyruvate kinase PKMHomo sapiens (human)
RNA bindingPyruvate kinase PKMHomo sapiens (human)
mRNA bindingPyruvate kinase PKMHomo sapiens (human)
protein tyrosine kinase activityPyruvate kinase PKMHomo sapiens (human)
pyruvate kinase activityPyruvate kinase PKMHomo sapiens (human)
protein bindingPyruvate kinase PKMHomo sapiens (human)
ATP bindingPyruvate kinase PKMHomo sapiens (human)
MHC class II protein complex bindingPyruvate kinase PKMHomo sapiens (human)
potassium ion bindingPyruvate kinase PKMHomo sapiens (human)
cadherin bindingPyruvate kinase PKMHomo sapiens (human)
3'-5'-RNA exonuclease activityReplicase polyprotein 1abSevere acute respiratory syndrome-related coronavirus
RNA-dependent RNA polymerase activityReplicase polyprotein 1abSevere acute respiratory syndrome-related coronavirus
cysteine-type endopeptidase activityReplicase polyprotein 1abSevere acute respiratory syndrome-related coronavirus
mRNA 5'-cap (guanine-N7-)-methyltransferase activityReplicase polyprotein 1abSevere acute respiratory syndrome-related coronavirus
mRNA (nucleoside-2'-O-)-methyltransferase activityReplicase polyprotein 1abSevere acute respiratory syndrome-related coronavirus
5'-3' RNA helicase activityReplicase polyprotein 1abSevere acute respiratory syndrome-related coronavirus
K63-linked deubiquitinase activityReplicase polyprotein 1abSevere acute respiratory syndrome-related coronavirus
K48-linked deubiquitinase activityReplicase polyprotein 1abSevere acute respiratory syndrome-related coronavirus
3'-5'-RNA exonuclease activityReplicase polyprotein 1abSevere acute respiratory syndrome coronavirus 2
RNA-dependent RNA polymerase activityReplicase polyprotein 1abSevere acute respiratory syndrome coronavirus 2
cysteine-type endopeptidase activityReplicase polyprotein 1abSevere acute respiratory syndrome coronavirus 2
mRNA 5'-cap (guanine-N7-)-methyltransferase activityReplicase polyprotein 1abSevere acute respiratory syndrome coronavirus 2
mRNA (nucleoside-2'-O-)-methyltransferase activityReplicase polyprotein 1abSevere acute respiratory syndrome coronavirus 2
mRNA guanylyltransferase activityReplicase polyprotein 1abSevere acute respiratory syndrome coronavirus 2
RNA endonuclease activity, producing 3'-phosphomonoestersReplicase polyprotein 1abSevere acute respiratory syndrome coronavirus 2
ISG15-specific peptidase activityReplicase polyprotein 1abSevere acute respiratory syndrome coronavirus 2
5'-3' RNA helicase activityReplicase polyprotein 1abSevere acute respiratory syndrome coronavirus 2
protein guanylyltransferase activityReplicase polyprotein 1abSevere acute respiratory syndrome coronavirus 2
protein bindingAmine oxidase [flavin-containing] AHomo sapiens (human)
primary amine oxidase activityAmine oxidase [flavin-containing] AHomo sapiens (human)
aliphatic amine oxidase activityAmine oxidase [flavin-containing] AHomo sapiens (human)
monoamine oxidase activityAmine oxidase [flavin-containing] AHomo sapiens (human)
flavin adenine dinucleotide bindingAmine oxidase [flavin-containing] AHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (23)

Processvia Protein(s)Taxonomy
nuclear chromosomeDNA topoisomerase 1Homo sapiens (human)
P-bodyDNA topoisomerase 1Homo sapiens (human)
fibrillar centerDNA topoisomerase 1Homo sapiens (human)
male germ cell nucleusDNA topoisomerase 1Homo sapiens (human)
nucleusDNA topoisomerase 1Homo sapiens (human)
nucleoplasmDNA topoisomerase 1Homo sapiens (human)
nucleolusDNA topoisomerase 1Homo sapiens (human)
perikaryonDNA topoisomerase 1Homo sapiens (human)
protein-DNA complexDNA topoisomerase 1Homo sapiens (human)
nucleolusDNA topoisomerase 1Homo sapiens (human)
extracellular regionPyruvate kinase PKMHomo sapiens (human)
nucleusPyruvate kinase PKMHomo sapiens (human)
cytoplasmPyruvate kinase PKMHomo sapiens (human)
mitochondrionPyruvate kinase PKMHomo sapiens (human)
rough endoplasmic reticulumPyruvate kinase PKMHomo sapiens (human)
cytosolPyruvate kinase PKMHomo sapiens (human)
ciliumPyruvate kinase PKMHomo sapiens (human)
vesiclePyruvate kinase PKMHomo sapiens (human)
secretory granule lumenPyruvate kinase PKMHomo sapiens (human)
collagen-containing extracellular matrixPyruvate kinase PKMHomo sapiens (human)
extracellular exosomePyruvate kinase PKMHomo sapiens (human)
extracellular vesiclePyruvate kinase PKMHomo sapiens (human)
ficolin-1-rich granule lumenPyruvate kinase PKMHomo sapiens (human)
cytoplasmPyruvate kinase PKMHomo sapiens (human)
double membrane vesicle viral factory outer membraneReplicase polyprotein 1abSevere acute respiratory syndrome-related coronavirus
double membrane vesicle viral factory outer membraneReplicase polyprotein 1abSevere acute respiratory syndrome coronavirus 2
mitochondrionAmine oxidase [flavin-containing] AHomo sapiens (human)
mitochondrial outer membraneAmine oxidase [flavin-containing] AHomo sapiens (human)
cytosolAmine oxidase [flavin-containing] AHomo sapiens (human)
mitochondrionAmine oxidase [flavin-containing] AHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (69)

Assay IDTitleYearJournalArticle
AID357212Antibacterial activity against Pseudomonas aeruginosa up to 100 ug/mL after 24 hrs by broth microdilution method2002Journal of natural products, Dec, Volume: 65, Issue:12
Antimicrobial activities of naphthazarins from Arnebia euchroma.
AID357227Cytotoxicity against human HeLa cells after 48 hrs by MTT assay2002Journal of natural products, Dec, Volume: 65, Issue:12
Antimicrobial activities of naphthazarins from Arnebia euchroma.
AID357213Ratio of MBC to MIC for Staphylococcus aureus2002Journal of natural products, Dec, Volume: 65, Issue:12
Antimicrobial activities of naphthazarins from Arnebia euchroma.
AID1188016Cytotoxicity against human MCF7 cells by MTT assay2014Bioorganic & medicinal chemistry letters, Sep-01, Volume: 24, Issue:17
Synthesis and evaluation of novel alkannin and shikonin oxime derivatives as potent antitumor agents.
AID357215Ratio of MBC to MIC for Enterococcus faecalis2002Journal of natural products, Dec, Volume: 65, Issue:12
Antimicrobial activities of naphthazarins from Arnebia euchroma.
AID481855Cytotoxicity against human LNCAP cells after 48 hrs by MTT assay2010Journal of natural products, May-28, Volume: 73, Issue:5
Cytotoxic naphthoquinones from Alkanna cappadocica ( perpendicular).
AID1881902Inhibition of PKM2 (unknown origin) Hie78, Lys207, Asn75, Ile51, Ser362, Ser205, Gly128 residues2022Journal of medicinal chemistry, 01-27, Volume: 65, Issue:2
A Perspective on Medicinal Chemistry Approaches for Targeting Pyruvate Kinase M2.
AID332847Antiinflammatory activity against thermal injury-induced edema in Wistar rat skin assessed as inhibition of edema at 50 ug treated topically relative to control
AID357228Cytotoxicity against human OVCAR-3 cells after 48 hrs by MTT assay2002Journal of natural products, Dec, Volume: 65, Issue:12
Antimicrobial activities of naphthazarins from Arnebia euchroma.
AID481857Cytotoxicity against human HeLa cells after 48 hrs by MTT assay2010Journal of natural products, May-28, Volume: 73, Issue:5
Cytotoxic naphthoquinones from Alkanna cappadocica ( perpendicular).
AID81147The compound was tested in vitro for its cytotoxicity against human HL-60 cancer cell line by MTT method at 1 uM concentration; Slight inhibition2002Bioorganic & medicinal chemistry letters, May-20, Volume: 12, Issue:10
Shikonin derivatives: synthesis and inhibition of human telomerase.
AID356964Antibacterial activity against vancomycin-resistant Enterococcus faecium F935 expressing VanA after 24 hrs by broth microdilution method2002Journal of natural products, Dec, Volume: 65, Issue:12
Antimicrobial activities of naphthazarins from Arnebia euchroma.
AID481858Cytotoxicity against human SKBR3 cells after 48 hrs by MTT assay2010Journal of natural products, May-28, Volume: 73, Issue:5
Cytotoxic naphthoquinones from Alkanna cappadocica ( perpendicular).
AID1188017Cytotoxicity against human K562 cells by MTT assay2014Bioorganic & medicinal chemistry letters, Sep-01, Volume: 24, Issue:17
Synthesis and evaluation of novel alkannin and shikonin oxime derivatives as potent antitumor agents.
AID228426Inhibition of topoisomerase I1998Bioorganic & medicinal chemistry letters, Dec-01, Volume: 8, Issue:23
Inhibition of topoisomerase I by naphthoquinone derivatives.
AID481859Cytotoxicity against human DU145 cells after 48 hrs by MTT assay2010Journal of natural products, May-28, Volume: 73, Issue:5
Cytotoxic naphthoquinones from Alkanna cappadocica ( perpendicular).
AID646469Binding affinity to human telomeric G-quadruplex DNA at 200 uM after 1 hr by ESI-TOF-MS analysis2012Bioorganic & medicinal chemistry letters, Feb-15, Volume: 22, Issue:4
Synthesis and human telomeric G-quadruplex DNA-binding activity of glucosaminosides of shikonin/alkannin.
AID1882806Anticancer activity against human MCF7 cells assessed as reduction in cell viability for 72 hrs by MTT assay2022European journal of medicinal chemistry, May-05, Volume: 235Recent advances of antitumor shikonin/alkannin derivatives: A comprehensive overview focusing on structural classification, synthetic approaches, and mechanisms of action.
AID357216Ratio of MBC to MIC for vancomycin-resistant Enterococcus faecium F935 expressing VanA2002Journal of natural products, Dec, Volume: 65, Issue:12
Antimicrobial activities of naphthazarins from Arnebia euchroma.
AID481856Cytotoxicity against human MCF7 cells after 48 hrs by MTT assay2010Journal of natural products, May-28, Volume: 73, Issue:5
Cytotoxic naphthoquinones from Alkanna cappadocica ( perpendicular).
AID481852Cytotoxicity against human PC3 cells after 48 hrs by MTT assay2010Journal of natural products, May-28, Volume: 73, Issue:5
Cytotoxic naphthoquinones from Alkanna cappadocica ( perpendicular).
AID1188018Cytotoxicity against human skin fibroblast cells by MTT assay2014Bioorganic & medicinal chemistry letters, Sep-01, Volume: 24, Issue:17
Synthesis and evaluation of novel alkannin and shikonin oxime derivatives as potent antitumor agents.
AID356965Antibacterial activity against vancomycin-resistant Enterococcus faecium F935 expressing VanA after 48 hrs by broth microdilution method2002Journal of natural products, Dec, Volume: 65, Issue:12
Antimicrobial activities of naphthazarins from Arnebia euchroma.
AID356963Antibacterial activity against Enterococcus faecalis after 48 hrs by broth microdilution method2002Journal of natural products, Dec, Volume: 65, Issue:12
Antimicrobial activities of naphthazarins from Arnebia euchroma.
AID356961Antibacterial activity against methicillin-resistant Staphylococcus aureus 8-8S after 48 hrs by broth microdilution method2002Journal of natural products, Dec, Volume: 65, Issue:12
Antimicrobial activities of naphthazarins from Arnebia euchroma.
AID1882808Cytotoxicity against human skin fibroblast cells incubated for 24 hrs by MTT assay2022European journal of medicinal chemistry, May-05, Volume: 235Recent advances of antitumor shikonin/alkannin derivatives: A comprehensive overview focusing on structural classification, synthetic approaches, and mechanisms of action.
AID356960Antibacterial activity against methicillin-resistant Staphylococcus aureus 8-8S after 24 hrs by broth microdilution method2002Journal of natural products, Dec, Volume: 65, Issue:12
Antimicrobial activities of naphthazarins from Arnebia euchroma.
AID356966Antibacterial activity against vancomycin-resistant Enterococcus faecalis CKU-17 expressing VanB after 24 hrs by broth microdilution method2002Journal of natural products, Dec, Volume: 65, Issue:12
Antimicrobial activities of naphthazarins from Arnebia euchroma.
AID356958Antibacterial activity against Staphylococcus aureus after 24 hrs by broth microdilution method2002Journal of natural products, Dec, Volume: 65, Issue:12
Antimicrobial activities of naphthazarins from Arnebia euchroma.
AID8453The compound was tested in vitro for its cytotoxicity against human A-549 cancer cell line by MTT method at 1 uM concentration; Slight inhibition2002Bioorganic & medicinal chemistry letters, May-20, Volume: 12, Issue:10
Shikonin derivatives: synthesis and inhibition of human telomerase.
AID1882772Anticancer activity against human MCF7 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay2022European journal of medicinal chemistry, May-05, Volume: 235Recent advances of antitumor shikonin/alkannin derivatives: A comprehensive overview focusing on structural classification, synthetic approaches, and mechanisms of action.
AID481854Cytotoxicity against human HepG2 cells after 48 hrs by MTT assay2010Journal of natural products, May-28, Volume: 73, Issue:5
Cytotoxic naphthoquinones from Alkanna cappadocica ( perpendicular).
AID356968Antibacterial activity against Escherichia coli up to 100 ug/mL after 24 hrs by broth microdilution method2002Journal of natural products, Dec, Volume: 65, Issue:12
Antimicrobial activities of naphthazarins from Arnebia euchroma.
AID356959Antibacterial activity against Staphylococcus aureus after 48 hrs by broth microdilution method2002Journal of natural products, Dec, Volume: 65, Issue:12
Antimicrobial activities of naphthazarins from Arnebia euchroma.
AID481861Cytotoxicity against human Hep3B cells after 48 hrs by MTT assay2010Journal of natural products, May-28, Volume: 73, Issue:5
Cytotoxic naphthoquinones from Alkanna cappadocica ( perpendicular).
AID356967Antibacterial activity against vancomycin-resistant Enterococcus faecalis CKU-17 expressing VanB after 48 hrs by broth microdilution method2002Journal of natural products, Dec, Volume: 65, Issue:12
Antimicrobial activities of naphthazarins from Arnebia euchroma.
AID332848Antiinflammatory activity against thermal injury-induced edema in Wistar rat skin assessed as inhibition of edema at 100 ug treated topically relative to control
AID357217Ratio of MBC to MIC for vancomycin-resistant Enterococcus faecalis CKU-17 expressing VanB2002Journal of natural products, Dec, Volume: 65, Issue:12
Antimicrobial activities of naphthazarins from Arnebia euchroma.
AID481850Cytotoxicity against human HT-29 cells after 48 hrs by MTT assay2010Journal of natural products, May-28, Volume: 73, Issue:5
Cytotoxic naphthoquinones from Alkanna cappadocica ( perpendicular).
AID1882773Anticancer activity against human K562 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay2022European journal of medicinal chemistry, May-05, Volume: 235Recent advances of antitumor shikonin/alkannin derivatives: A comprehensive overview focusing on structural classification, synthetic approaches, and mechanisms of action.
AID332845Decrease in histamine-induced capillary permeability in Wistar rat assessed as inhibition of pontamine sky blue 6BX dye leakage at 50 ug treated topically relative to control
AID481851Cytotoxicity against human MDA-MB-231 cells after 48 hrs by MTT assay2010Journal of natural products, May-28, Volume: 73, Issue:5
Cytotoxic naphthoquinones from Alkanna cappadocica ( perpendicular).
AID1188015Cytotoxicity against human DU145 cells by MTT assay2014Bioorganic & medicinal chemistry letters, Sep-01, Volume: 24, Issue:17
Synthesis and evaluation of novel alkannin and shikonin oxime derivatives as potent antitumor agents.
AID1882774Cytotoxicity against human skin fibroblast cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay2022European journal of medicinal chemistry, May-05, Volume: 235Recent advances of antitumor shikonin/alkannin derivatives: A comprehensive overview focusing on structural classification, synthetic approaches, and mechanisms of action.
AID1882700Anticancer activity against human DU-145 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay2022European journal of medicinal chemistry, May-05, Volume: 235Recent advances of antitumor shikonin/alkannin derivatives: A comprehensive overview focusing on structural classification, synthetic approaches, and mechanisms of action.
AID332846Decrease in histamine-induced capillary permeability in Wistar rat assessed as inhibition of pontamine sky blue 6BX dye leakage at 100 ug treated topically relative to control
AID481863Cytotoxicity against mouse 3T3 cells after 48 hrs by MTT assay2010Journal of natural products, May-28, Volume: 73, Issue:5
Cytotoxic naphthoquinones from Alkanna cappadocica ( perpendicular).
AID1882807Anticancer activity against human HCT-15 cells assessed as reduction in cell viability for 72 hrs by MTT assay2022European journal of medicinal chemistry, May-05, Volume: 235Recent advances of antitumor shikonin/alkannin derivatives: A comprehensive overview focusing on structural classification, synthetic approaches, and mechanisms of action.
AID481853Cytotoxicity against human AU565 cells after 48 hrs by MTT assay2010Journal of natural products, May-28, Volume: 73, Issue:5
Cytotoxic naphthoquinones from Alkanna cappadocica ( perpendicular).
AID1881860Inhibition of PKM2 (unknown origin)2022Journal of medicinal chemistry, 01-27, Volume: 65, Issue:2
A Perspective on Medicinal Chemistry Approaches for Targeting Pyruvate Kinase M2.
AID357226Cytotoxicity against human HepG2 cells after 48 hrs by MTT assay2002Journal of natural products, Dec, Volume: 65, Issue:12
Antimicrobial activities of naphthazarins from Arnebia euchroma.
AID481860Cytotoxicity against human Saos2 cells after 48 hrs by MTT assay2010Journal of natural products, May-28, Volume: 73, Issue:5
Cytotoxic naphthoquinones from Alkanna cappadocica ( perpendicular).
AID1882805Anticancer activity against human K562 cells assessed as reduction in cell viability for 72 hrs by MTT assay2022European journal of medicinal chemistry, May-05, Volume: 235Recent advances of antitumor shikonin/alkannin derivatives: A comprehensive overview focusing on structural classification, synthetic approaches, and mechanisms of action.
AID481862Cytotoxicity against african green monkey Vero cells after 48 hrs by MTT assay2010Journal of natural products, May-28, Volume: 73, Issue:5
Cytotoxic naphthoquinones from Alkanna cappadocica ( perpendicular).
AID152352The compound was tested in vitro for its cytotoxicity against human P-388 cancer cell line by MTT method at 1 uM concentration; Slight inhibition2002Bioorganic & medicinal chemistry letters, May-20, Volume: 12, Issue:10
Shikonin derivatives: synthesis and inhibition of human telomerase.
AID356962Antibacterial activity against Enterococcus faecalis after 24 hrs by broth microdilution method2002Journal of natural products, Dec, Volume: 65, Issue:12
Antimicrobial activities of naphthazarins from Arnebia euchroma.
AID357214Ratio of MBC to MIC for methicillin-resistant Staphylococcus aureus 8-8S2002Journal of natural products, Dec, Volume: 65, Issue:12
Antimicrobial activities of naphthazarins from Arnebia euchroma.
AID1494881Growth inhibition of Staphylococcus aureus Newman at 50 uM measured every hour2018Bioorganic & medicinal chemistry letters, 06-01, Volume: 28, Issue:10
Quinone skeleton as a new class of irreversible inhibitors against Staphylococcus aureus sortase A.
AID1494880Inhibition of Staphylococcus aureus SrtA deltaN24 mutant transpeptidation activity using abz-LPATG-dnp as substrate preincubated for 10 mins followed by substrate addition measured every 2 mins for 20 mins by FRET assay2018Bioorganic & medicinal chemistry letters, 06-01, Volume: 28, Issue:10
Quinone skeleton as a new class of irreversible inhibitors against Staphylococcus aureus sortase A.
AID1494883Inhibition of Staphylococcus aureus SrtA deltaN24 mutant assessed as decrease in transpeptidation of IsdA (64 to 323 residues) incubated for 1.25 hrs in presence of NH2-Gly3 nucleophile by SDS-PAGE method2018Bioorganic & medicinal chemistry letters, 06-01, Volume: 28, Issue:10
Quinone skeleton as a new class of irreversible inhibitors against Staphylococcus aureus sortase A.
AID1803933high-throughput activity assay from Article 10.1038/s41586-020-2223-y: \\Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors \\2020Nature, 06, Volume: 582, Issue:7811
Structure of M
AID1805801Various Assay from Article 10.1021/acs.jmedchem.1c00409: \\Perspectives on SARS-CoV-2 Main Protease Inhibitors.\\2021Journal of medicinal chemistry, 12-09, Volume: 64, Issue:23
Perspectives on SARS-CoV-2 Main Protease Inhibitors.
AID1803934Antiviral activity assay from Article 10.1038/s41586-020-2223-y: \\Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors \\2020Nature, 06, Volume: 582, Issue:7811
Structure of M
AID1801570MAO Inhibition Assay from Article 10.1111/cbdd.12708: \\Evaluation of Natural and Synthetic 1,4-naphthoquinones as Inhibitors of Monoamine Oxidase.\\2016Chemical biology & drug design, May, Volume: 87, Issue:5
Evaluation of Natural and Synthetic 1,4-naphthoquinones as Inhibitors of Monoamine Oxidase.
AID152352The compound was tested in vitro for its cytotoxicity against human P-388 cancer cell line by MTT method at 1 uM concentration; Slight inhibition2002Bioorganic & medicinal chemistry letters, May-20, Volume: 12, Issue:10
Shikonin derivatives: synthesis and inhibition of human telomerase.
AID8453The compound was tested in vitro for its cytotoxicity against human A-549 cancer cell line by MTT method at 1 uM concentration; Slight inhibition2002Bioorganic & medicinal chemistry letters, May-20, Volume: 12, Issue:10
Shikonin derivatives: synthesis and inhibition of human telomerase.
AID81147The compound was tested in vitro for its cytotoxicity against human HL-60 cancer cell line by MTT method at 1 uM concentration; Slight inhibition2002Bioorganic & medicinal chemistry letters, May-20, Volume: 12, Issue:10
Shikonin derivatives: synthesis and inhibition of human telomerase.
AID540299A screen for compounds that inhibit the MenB enzyme of Mycobacterium tuberculosis2010Bioorganic & medicinal chemistry letters, Nov-01, Volume: 20, Issue:21
Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.
AID588519A screen for compounds that inhibit viral RNA polymerase binding and polymerization activities2011Antiviral research, Sep, Volume: 91, Issue:3
High-throughput screening identification of poliovirus RNA-dependent RNA polymerase inhibitors.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (80)

TimeframeStudies, This Drug (%)All Drugs %
pre-19904 (5.00)18.7374
1990's6 (7.50)18.2507
2000's18 (22.50)29.6817
2010's34 (42.50)24.3611
2020's18 (22.50)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 54.01

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index54.01 (24.57)
Research Supply Index1.95 (2.92)
Research Growth Index4.72 (4.65)
Search Engine Demand Index79.57 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (54.01)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (1.28%)5.53%
Trials0 (0.00%)5.53%
Reviews3 (3.85%)6.00%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Observational0 (0.00%)0.25%
Other74 (94.87%)84.16%
Other6 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]